Frontiers in Endocrinology | Cancer Endocrinology

Original Research

Accepted on 13 Aug 2025

Epidemiological study of thyroid cancer at global, regional, and national levels from 1990 to 2021: an analysis derived from the Global Burden of Disease Study 2021

in Cancer Endocrinology

Lu Zhang
Liangliang Jiang
Rong Xu
Xuemei Zhang
Boxun Zhang
Rensong Yue

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1644270

229 views

Original Research

Published on 11 Aug 2025

Clinicopathological features and outcomes in patients with concurrent medullary and papillary thyroid carcinoma

in Cancer Endocrinology

Ruonan Sun
Xueting Liu
Jiabin Liu
Zhihui Li
Yichao Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1625989

381 views

Original Research

Published on 11 Aug 2025

Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?

in Cancer Endocrinology

Tugba Matlim Ozel
Sezer Akbulut
Aykut Celik
Gorkem Yildiz
Hamit Yucel Barut
Fatih Mert Dogukan
Serkan Sari

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1520539

339 views

Original Research

Accepted on 08 Aug 2025

Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma

in Cancer Endocrinology

Li Liu
Fang Wei

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1584618

124 views

Original Research

Accepted on 08 Aug 2025

MANAGEMENT OF TYPE I GASTRIC-NEUROENDOCRINE TUMORS: THE LESS THE BETTER?

in Cancer Endocrinology

Roberta Elisa Rossi
Benedetta Masoni
Valeria Poletti
Roberta Maselli
Silvia Carrara
Alexia Francesca Bertuzzi
Silvia Uccella
Andrea Lania
Alessandro Zerbi
Cesare Hassan

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1666699

140 views

Correction

Accepted on 08 Aug 2025

Correction: <>

in Cancer Endocrinology

Jiayu Chen
Haochen Peng
Yawen Shao
Zhenzhen Wu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1681661

Review

Accepted on 04 Aug 2025

Progress of estrogen receptor and spliceosome in endometrial carcinoma

in Cancer Endocrinology

Ziqi Hong
Ting Mo
Peiquan zhou
Jian Chen
Xin Li

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1586191

228 views

Brief Research Report

Accepted on 04 Aug 2025

Insulin-like peptide 3 (INSL3) is not a biomarker for pancreatic ductal adenocarcinoma

in Cancer Endocrinology

Ravinder Anand-Ivell
Xinyuan Yang
Ruediger Braun
Hendrik Ungefroren
Richard Ivell

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1625906

170 views

Original Research

Published on 01 Aug 2025

Postmenopausal ovarian hyperandrogenism of surgically treated patients: a case report and scoping review with individual patient’s data analysis

in Cancer Endocrinology

Angelo Forte
Lanfranco D’Elia
Carmine De Luca
Antonella Fiore
Antonio Barbato
Veronica Abate
Anita Vergatti
Nunzia Verde
Gianpaolo De Filippo
Pietro Venetucci

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1495930

561 views

Mini Review

Accepted on 31 Jul 2025

Dual-Tracer 18 F-FDG and 18 F-AlF-NOTA-octreotide PET/CT imaging in oncocytic thyroid adenoma: a case report and literature review

in Cancer Endocrinology

Jing Li

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1612851

118 views

Original Research

Published on 31 Jul 2025

The impact of altered gut microbiota and lipid metabolism on the progression of endometrial cancer in overweight populations

in Cancer Endocrinology

Jiayu Chen
Haochen Peng
Yawen Shao
Zhenzhen Wu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1610534

640 views

Editorial

Published on 31 Jul 2025

Editorial: Endocrine aspects of gynaecological cancers, volume II

in Cancer Endocrinology

Stefano Palomba

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1659320

272 views

Review

Accepted on 30 Jul 2025

Tumor Microenvironment and Metabolic Reprogramming: Unraveling the Complex Interplay in Gastrointestinal Tumor Liver Metastasis

in Cancer Endocrinology

Song Wang
Zheng Ma
Lianghong Lv
Qian Yu
Shanglong Liu
Yun Lu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1616661

118 views

Original Research

Accepted on 30 Jul 2025

Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma

in Cancer Endocrinology

Sabine Waechter

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1619875

129 views

Review

Published on 25 Jul 2025

Metabolism and epigenetics in cancer: toward personalized treatment

in Cancer Endocrinology

Xiaoman Zhang
Dequan Liu
Sulan Yin
Yaru Gao
Xiaorui Li
Guangzhen Wu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1530578

1,019 views

Review

Published on 24 Jul 2025

Management of liver metastases from non-functional gastroenteropancreatic neuroendocrine tumors: a systematic review

in Cancer Endocrinology

Jun-shuai Xue
Yi Yang
Zhen Huang
Hong Zhao
Xiao Chen
Jian-qiang Cai

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1601185

1,359 views